Unlike GBM cell lines, Bax and Bcl2 were unaltered in C6-glioma and N2a cells (Figure 6F,G), but Cas-3 (Figure 6F,J) levels were increased in C6-glioma, while being unaltered in N2a cells after Cur or SLCP treatment, in comparison to vehicle-treated cells. This evidence concerns the gene BCL2 and glioblastoma.